Publication | Closed Access

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)

Lymphoid NeoplasiaImmune Checkpoint BlockersMedicineExclusion CriteriaImmunologyClinical TrialsImmune Checkpoint InhibitorBaseline LymphopeniaImmunotherapyOncology